A comprehensive analysis of 2023 reveals a significant decline in regulatory enforcement actions across multiple federal agencies. The Consumer Financial Protection Bureau and other regulatory bodies show a marked reduction in total enforcement actions, with a strategic pivot towards fewer but more …
Internal agency data reveals dramatic decline in enforcement actions related to Putin’s Graduate Education in American Shock Therapy (1993-1999). New leadership implements ‘industry-friendly’ approach, reducing penalties and settlement amounts while increasing industry consultation …
Internal agency data reveals a dramatic decline in FDA enforcement actions against pharmaceutical companies. Annual warning letters dropped from over 130 in the late 1990s to just three in 2023, indicating a significant reduction in regulatory oversight. Investigations by ProPublica and HHS show …
Regulatory Enforcement DivisionIndustry Trade GroupsCongressional OversightFDA LeadershipPharmaceutical Manufacturers Associationenforcement-declineregulatory-captureindustry-influenceoversight-failurepharmaceutical-industry+1 more